Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-08-31 | Michael Dawson, M.D. |
| 2024-02-06 | Michael Dawson, M.D.(13) Includes 300 shares of common stock. Dr. Dawson ceased to be an officer of the Company effective October 11, 2022. |
Data sourced from SEC filings. Last updated: 2026-03-09